Insider Selling: HealthEquity (NASDAQ:HQY) EVP Sells $234,650.00 in Stock

HealthEquity, Inc. (NASDAQ:HQY) EVP Michael Henry Fiore sold 2,470 shares of the stock in a transaction dated Thursday, July 2nd. The stock was sold at an average price of $95.00, for a total value of $234,650.00. Following the sale, the executive vice president directly owned 56,643 shares in the company, valued at $5,381,085. This trade represents a 4.18% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Michael Henry Fiore also recently made the following trade(s):

• On Friday, May 29th, Michael Henry Fiore sold 3,142 shares of HealthEquity stock. The shares were sold at an average price of $95.00, for a total transaction of $298,490.00.

HealthEquity Stock Up 0.1%

HQY opened at $94.81 on Friday. The firm has a market capitalization of $7.93 billion, a P/E ratio of 35.51, a price-to-earnings-growth ratio of 1.59 and a beta of 0.21. HealthEquity, Inc. has a one year low of $72.76 and a one year high of $105.96. The company has a fifty day moving average price of $87.20 and a 200-day moving average price of $84.60. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.44 and a quick ratio of 3.44.

HealthEquity (NASDAQ:HQY) last posted its earnings results on Thursday, May 28th. The company reported $1.24 EPS for the quarter, topping the consensus estimate of $1.11 by $0.13. The business had revenue of $354.64 million during the quarter, compared to analysts’ expectations of $352.02 million. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The firm’s revenue was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Equities research analysts expect that HealthEquity, Inc. will post 3.92 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on HQY shares. Deutsche Bank Aktiengesellschaft upped their target price on HealthEquity from $120.00 to $128.00 and gave the stock a “buy” rating in a research note on Thursday, March 19th. JPMorgan Chase & Co. reduced their price target on HealthEquity from $129.00 to $123.00 and set an “overweight” rating on the stock in a report on Wednesday, March 18th. BMO Capital Markets upgraded shares of HealthEquity from a “market perform” rating to an “outperform” rating and upped their price objective for the stock from $85.00 to $105.00 in a report on Thursday, April 9th. Citigroup reissued a “market outperform” rating on shares of HealthEquity in a research report on Monday, June 1st. Finally, Barrington Research reissued an “outperform” rating and set a $110.00 price target on shares of HealthEquity in a research report on Friday, May 22nd. Eleven research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, HealthEquity presently has a consensus rating of “Moderate Buy” and an average price target of $110.57.

Institutional Investors Weigh In On HealthEquity

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Acumen Wealth Advisors LLC bought a new stake in shares of HealthEquity in the fourth quarter worth $27,000. Caitong International Asset Management Co. Ltd increased its position in HealthEquity by 1,723.5% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company’s stock valued at $28,000 after acquiring an additional 293 shares during the last quarter. Aster Capital Management DIFC Ltd bought a new position in HealthEquity in the fourth quarter valued at about $28,000. Leonteq Securities AG lifted its holdings in HealthEquity by 159.9% in the first quarter. Leonteq Securities AG now owns 382 shares of the company’s stock valued at $32,000 after acquiring an additional 235 shares during the period. Finally, Axiom Investment Management LLC purchased a new position in HealthEquity in the first quarter worth about $33,000. Hedge funds and other institutional investors own 99.55% of the company’s stock.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.